Validity and Reliability Evaluation of the PRO-CTCAE for Adult-type Diffuse Gliomas Patients in Chinese Population

CompletedOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

September 19, 2022

Primary Completion Date

January 1, 2025

Study Completion Date

February 1, 2025

Conditions
GliomaPatient Reported Outcome MeasuresSelf ReportAdverse Effects
Trial Locations (14)

200040

Department of Neurologic Surgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai

Unknown

Beijing Tian Tan Hospital, Capital Medical University, Beijing

Xuan Wu Hospital, Capital Medical University, Beijing

The First Affiliated Hospital of Fujian Medical University, Fuzhou

Guangdong Sanjiu Brain Hospital, Guangzhou

Sun Yat-sen University Cancer Center, Guangzhou

Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan

Jiangsu People's Hospital, Nanjing

Xijing Hospital, Xi'an

Changhai Hospital, Shanghai

East Hospital Affiliated To Tongji University, Shanghai

Shanghai Proton and Heavy Ion Hospital, Shanghai

The First Affiliated Hospital of Kunming Medical University, Kunming

The Second Affiliated Hospital of Zhejiang University, Hangzhou

All Listed Sponsors
lead

Huashan Hospital

OTHER